In glioma, HOTAIR has been shown to activate the NF-κB pathway, potentially by suppressing upstream inhibitors like UBXN1, leading to increased NF-κB nuclear translocation and subsequent binding to the PD-L1 promoter to drive its expression (Wang et al., 2021). This evidence concerns the gene NFKB1 and central nervous system cancer.